CALR and melanoma: Moreover, we have also demonstrated that the HS treatment of melanoma cells before their final lysis for TRIMEL generation increases calreticulin (CALR) plasma membrane translocation and induces the release of high mobility group box 1 (HMGB1) protein [11] and two well-described DAMPs [16, 17].